Ann M. Chan

Biochemistry, Genetics and Molecular BiologyMedicineImmunology and MicrobiologyNeuroscience

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “EMP2 Is a Novel Regulator of Stemness in Breast Cancer Cells”.

EMP2 Is a Novel Regulator of Stemness in Breast Cancer Cells

Molecular Cancer Therapeutics(2020)10.1158/1535-7163.mct-19-0850

N/A

0DataRank · unranked

23 citations

Meagan Kiyohara, Vei Mah, Sean McDermott, Dana Bazzoun, Jessica Tsui +19 more

Epithelial membrane protein 2 (EMP2) regulates hypoxia-induced angiogenesis in the adult retinal pigment epithelial cell lines

Scientific Reports(2022)10.1038/s41598-022-22696-x

N/A

0DataRank · unranked

8 citations

Nina Cherian, Lucia Liu, Ann M. Chan, Brian Aguirre, Alison Chu +7 more

EMP2 Serves as a Functional Biomarker for Chemotherapy-Resistant Triple-Negative Breast Cancer

Cancers(2024)10.3390/cancers16081481

N/A

0DataRank · unranked

5 citations

Brian Aguirre, Lucia Liu, Vei Mah, Justin M. Balko, Jessica Tsui +13 more

GrB-Fc-KS49, an anti-EMP2 granzyme B fusion protein therapeutic alters immune cell infiltration and suppresses breast cancer growth

Journal for ImmunoTherapy of Cancer(2024)10.1136/jitc-2024-008891

N/A

0DataRank · unranked

3 citations

Brian Aguirre, Cheng-Hsiang Lu, Anubhav Chandla, Nidhi Kejriwal, Lucia Liu +9 more